vs

Side-by-side financial comparison of Oncology Institute, Inc. (TOI) and XPEL, Inc. (XPEL). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $122.3M, roughly 1.2× XPEL, Inc.). XPEL, Inc. runs the higher net margin — 11.0% vs -5.3%, a 16.3% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 13.7%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $1.6M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 16.5%).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

XPEL, Inc. is a global provider of high-performance surface protection solutions primarily for automotive use. Core offerings include paint protection films, window tints, and ceramic coatings, serving vehicle owners, dealerships, and professional installers across North America, Europe, and Asia Pacific.

TOI vs XPEL — Head-to-Head

Bigger by revenue
TOI
TOI
1.2× larger
TOI
$142.0M
$122.3M
XPEL
Growing faster (revenue YoY)
TOI
TOI
+27.9% gap
TOI
41.6%
13.7%
XPEL
Higher net margin
XPEL
XPEL
16.3% more per $
XPEL
11.0%
-5.3%
TOI
More free cash flow
TOI
TOI
$580.0K more FCF
TOI
$2.2M
$1.6M
XPEL
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
16.5%
XPEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TOI
TOI
XPEL
XPEL
Revenue
$142.0M
$122.3M
Net Profit
$-7.5M
$13.4M
Gross Margin
41.9%
Operating Margin
-4.9%
12.7%
Net Margin
-5.3%
11.0%
Revenue YoY
41.6%
13.7%
Net Profit YoY
43.0%
50.7%
EPS (diluted)
$-0.04
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TOI
TOI
XPEL
XPEL
Q4 25
$142.0M
$122.3M
Q3 25
$136.6M
$125.4M
Q2 25
$119.8M
$124.7M
Q1 25
$104.4M
$103.8M
Q4 24
$100.3M
$107.5M
Q3 24
$99.9M
$112.9M
Q2 24
$98.6M
$109.9M
Q1 24
$94.7M
$90.1M
Net Profit
TOI
TOI
XPEL
XPEL
Q4 25
$-7.5M
$13.4M
Q3 25
$-16.5M
$12.9M
Q2 25
$-17.0M
$16.3M
Q1 25
$-19.6M
$8.6M
Q4 24
$-13.2M
$8.9M
Q3 24
$-16.1M
$14.9M
Q2 24
$-15.5M
$15.0M
Q1 24
$-19.9M
$6.7M
Gross Margin
TOI
TOI
XPEL
XPEL
Q4 25
41.9%
Q3 25
41.8%
Q2 25
42.9%
Q1 25
42.3%
Q4 24
40.6%
Q3 24
42.5%
Q2 24
43.5%
Q1 24
42.0%
Operating Margin
TOI
TOI
XPEL
XPEL
Q4 25
-4.9%
12.7%
Q3 25
-5.9%
13.4%
Q2 25
-9.4%
15.5%
Q1 25
-9.5%
10.7%
Q4 24
-11.9%
11.5%
Q3 24
-13.9%
16.3%
Q2 24
-16.6%
17.5%
Q1 24
-19.0%
10.2%
Net Margin
TOI
TOI
XPEL
XPEL
Q4 25
-5.3%
11.0%
Q3 25
-12.1%
10.3%
Q2 25
-14.2%
13.1%
Q1 25
-18.8%
8.3%
Q4 24
-13.1%
8.3%
Q3 24
-16.1%
13.2%
Q2 24
-15.7%
13.7%
Q1 24
-21.0%
7.4%
EPS (diluted)
TOI
TOI
XPEL
XPEL
Q4 25
$-0.04
$0.48
Q3 25
$-0.14
$0.47
Q2 25
$-0.15
$0.59
Q1 25
$-0.21
$0.31
Q4 24
$-0.14
$0.33
Q3 24
$-0.18
$0.54
Q2 24
$-0.17
$0.54
Q1 24
$-0.22
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TOI
TOI
XPEL
XPEL
Cash + ST InvestmentsLiquidity on hand
$50.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-15.7M
$280.3M
Total Assets
$164.7M
$382.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TOI
TOI
XPEL
XPEL
Q4 25
$50.9M
Q3 25
$64.5M
Q2 25
$49.6M
Q1 25
$23.5M
Q4 24
$22.1M
Q3 24
$21.0M
Q2 24
$9.9M
$15.0M
Q1 24
$29.8M
$8.6M
Stockholders' Equity
TOI
TOI
XPEL
XPEL
Q4 25
$-15.7M
$280.3M
Q3 25
$-12.3M
$269.3M
Q2 25
$-9.0M
$255.7M
Q1 25
$5.1M
$235.5M
Q4 24
$3.6M
$225.5M
Q3 24
$15.5M
$218.7M
Q2 24
$29.2M
$201.9M
Q1 24
$41.3M
$186.4M
Total Assets
TOI
TOI
XPEL
XPEL
Q4 25
$164.7M
$382.5M
Q3 25
$163.6M
$387.7M
Q2 25
$159.8M
$318.1M
Q1 25
$164.0M
$294.8M
Q4 24
$172.7M
$285.6M
Q3 24
$179.2M
$273.0M
Q2 24
$179.6M
$261.8M
Q1 24
$204.5M
$258.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TOI
TOI
XPEL
XPEL
Operating Cash FlowLast quarter
$3.2M
$2.7M
Free Cash FlowOCF − Capex
$2.2M
$1.6M
FCF MarginFCF / Revenue
1.5%
1.3%
Capex IntensityCapex / Revenue
0.7%
0.9%
Cash ConversionOCF / Net Profit
0.20×
TTM Free Cash FlowTrailing 4 quarters
$-27.8M
$62.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TOI
TOI
XPEL
XPEL
Q4 25
$3.2M
$2.7M
Q3 25
$-12.6M
$33.2M
Q2 25
$-10.2M
$27.9M
Q1 25
$-5.0M
$3.2M
Q4 24
$4.2M
$6.3M
Q3 24
$819.0K
$19.6M
Q2 24
$-15.7M
$26.9M
Q1 24
$-15.9M
$-5.0M
Free Cash Flow
TOI
TOI
XPEL
XPEL
Q4 25
$2.2M
$1.6M
Q3 25
$-13.2M
$32.2M
Q2 25
$-11.4M
$26.9M
Q1 25
$-5.3M
$2.2M
Q4 24
$2.4M
$4.7M
Q3 24
$417.0K
$18.3M
Q2 24
$-17.5M
$25.1M
Q1 24
$-16.5M
$-7.0M
FCF Margin
TOI
TOI
XPEL
XPEL
Q4 25
1.5%
1.3%
Q3 25
-9.7%
25.6%
Q2 25
-9.5%
21.6%
Q1 25
-5.1%
2.1%
Q4 24
2.4%
4.4%
Q3 24
0.4%
16.2%
Q2 24
-17.7%
22.8%
Q1 24
-17.4%
-7.7%
Capex Intensity
TOI
TOI
XPEL
XPEL
Q4 25
0.7%
0.9%
Q3 25
0.4%
0.8%
Q2 25
1.0%
0.8%
Q1 25
0.3%
1.0%
Q4 24
1.8%
1.5%
Q3 24
0.4%
1.1%
Q2 24
1.9%
1.6%
Q1 24
0.6%
2.2%
Cash Conversion
TOI
TOI
XPEL
XPEL
Q4 25
0.20×
Q3 25
2.56×
Q2 25
1.71×
Q1 25
0.38×
Q4 24
0.71×
Q3 24
1.31×
Q2 24
1.79×
Q1 24
-0.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

XPEL
XPEL

Products$90.9M74%
Service Revenue Installation Labor$23.8M19%
Service Revenue Cutbank Credits$4.1M3%
Service Revenue Software$2.2M2%

Related Comparisons